RHEA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RHEA - overview
Location
Singapore, -, Singapore
Primary Industry
Healthcare
About
Based in Singapore, Recharge RHEA Holdings provides reproductive health services that include comprehensive care for intended parents. In May 2024, the firm raised USD 10 million in venture funding led by returning investor Thiel Capital, with participation from investors LifeX Ventures, Blue Lion Global, and FJ Labs. As of 2024, the company is headed by its CEO Margaret Wang. The company offers a wide range of integrated services to support the fertility journey of intended parents.
The firm service range includes GenPrime Clinic Group which consists of networks of fertility clinics. Additionally, the company also offers a technology-driven Rhea Lab that provides insights into patient's end-to-end reproductive health. Moreover, it provides fertility wellness products and services by partnering with various wellness providers. The company plans to use the May 2024 funding to support the expansion of its services.
Current Investors
FJ Labs, Thiel Capital, LifeX Ventures
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Clinics/Outpatient Services
Website
www.rhea-fertility.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.